The current status of cardiovascular risk factors in Turkey;Kardiyovasküler risk faktörlerinin ülkemizdeki durumu

Turk Kardiyoloji Dernegi Arsivi

Volumn 39, Issue SUPP- 4, 2011, Pages 1-5

  Abaci, Adnan ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Cardiovascular diseases prevention control; Prevalence; Risk factors; Turkey epidemiology

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; MEDICAL RESEARCH; REVIEW; TURKEY (REPUBLIC);

EID: 84862862702     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: 10.5543/tkda.2011.abaci     Document Type: Review

References (20)

1. Onat A, Uǧur M, Tuncer M, Ayhan E, Kaya Z, Küçü kdurmaz Z, et al. Age at death in the Turkish Adult Risk Factor Study: temporal trend and regional distribution at 56,700 person-years' follow-up. [Article in Turkish] Türk Kardiyol Dern Arş 2009;37:155-60.
2. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206.
3. Onat A, Şenocak M, Örnek E, Gözükara Y, Şurdum-Avci G, Karaaslan Y ve ark. Türkiye'de erişkinlerde kalp hastaliǧive risk faktörleri sikliǧi taramasi: 5. Hipertansiyon ve sigara içimi. Türk Kardiyol Dern Arş 1991;19:169-77.
4. Altun B, Arici M, Nergizoǧlu G, Derici U, Karatan O, Turgan C, et al. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. J Hypertens 2005;23:1817-23.
5. Onat A, Sansoy V, Yildirim B, Keleş İ, Çetinkaya A, Aksu H ve ark. Erişkinlerimizde kan basinci: 8 yillik seyri, tedavi orani, koroner kalp hastaliǧi ile ve bazi etkenlerle ilişkileri. Türk Kardiyol Dern Arş 1999;27:136-43.
6. Onat A, Doǧan Y, Uyarel H, Ceyhan K, Uzunlar B, YaziciM ve ark. Erişkinlerimizde kan basinci ve kontrol altinda tutulmasi yönünde gelişme. Türk Kardiyol Dern Arş2002;30:749- 57.
7. Arici M, Turgan C, Altun B, Sindel S, Erbay B, Derici U, et al. Hypertension incidence in Turkey (HinT): a population-based study. J Hypertens 2010;28:240-4.
8. Abaci A, Oǧuz A, Kozan Ö, Toprak N, Şenocak H, Deǧer N, et al. Treatment and control of hypertension in Turkish population: a survey on high blood pressure in primary care (the TURKSAHA study). J Hum Hypertens 2006;20:355-61.
9. Banegas JR, López-García E, Dallongeville J, Guallar E, Halcox JP, Borghi C, et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J 2011;32:2143-52.
10. Kotseva K, Wood D, De Backer G, De Bacquer D, PyöräläK, Keil U, et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009;16:121-37.
11. Tokgözoǧlu L, Kaya, EB, Erol C, Ergene O; EUROASPIRE III Turkey Study Group. EUROASPIRE III: a comparison between Turkey and Europe. [Article in Turkish] Türk Kardiyol Dern Arş 2010;38:164-72.
12. Onat A. Türk halkinda lipid, lipoprotein ve apolipoproteinler. In: Onat A, editör. TEKHARF 2009. Türk halkinin kusurlu kalp saǧliǧi: sirrina işik, tibba önemli katki. İstanbul: Cortex İletişim Hizmetleri; 2009. s. 39-58. Erişim: http://tekharf.org/2009.html.
13. Mahley RW, Palaoǧlu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995;36:839-59.
14. Kozan Ö, Oǧuz A, Abaci A, Erol C, Öngen Z, Temizhan A, et al. Prevalence of the metabolic syndrome among Turkish adults. Eur J Clin Nutr. 2007;61:548-53.
15. Uzunlulu M, Oǧuz A, Tigen K. High-density lipoprotein cholesterol in coronary artery disease patients: is it as low as expected? Anadolu Kardiyol Derg 2005;5:268-70.
16. İlerigelen B, Kabakci G, Koylan N, Kozan Ö, Büyüköztürk K. Coexisting dyslipidemia in hypertensive patients. [Abstract] Atherosclerosis 2005;6 Suppl:156.
17. Satman İ, Yilmaz T, Şengül A, Salman S, Salman F, Uygur S, et al. Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabetes Care 2002;25:1551-6.
18. Türkiye Diyabet, Hipertansiyon, Obezite ve Endokrinolojik Hastaliklar Prevalans Çalişmasi II (TURDEP II) sonuçlarinin özeti. Erişim: http://www.istanbul.edu.tr/itf/attachments/021- turdep.2.sonuclarinin.aciklamasi.pdf.
19. Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med 2000;160:939-44.
20. Onat A, Aksu H, Uslu N, Keleş İ, Çetinkaya A, Yildirim B ve ark. Türk erişkinlerinde sigara içimi: Kadinlarimizda tiryakilik artma yolunda. Türk Kardiyol Dern Arş 1999;27:697-700.